subtypes, all of which are expressed in the kidney. Mice deficient in specific dopamine receptors have been generated to provide holistic assessment on the varying physiological roles of each receptor subtype. This review examines recent studies on these mutant mouse models and evaluates the impact of individual dopamine receptor subtypes on blood pressure regulation.
Introduction
Hypertension, which affects a quarter of all middle-aged adults, is one of the most common risk factors of cardiovascular disease. High blood pressure is a phenotype expressed by several disorders, and results from an aberrant interaction between genetic and environmental factors. Hypertension occurs because of the increased activity of pro-hypertensive systems and/or decreased activity of antihypertensive systems [1] [2] [3] [4] , one of which is the dopaminergic system [1, 2] . Therefore, a dysfunction in the dopaminergic pathway may be a mechanism in the development of essential hypertension.
Mammalian dopamine receptors are G protein-coupled receptors (GPCRs) belonging to the α group of the rhodopsin family (Class A, Family A, or Family 1) and include five subtypes identified by molecular cloning [5, 6] . The D 1 and D 5 receptor subtypes are known as D 1 -like receptors and couple to G proteins G s and G olf to stimulate adenylyl cyclase activity. The D 2 , D 3 , and D 4 receptor subtypes are known as D 2 -like receptors and couple to G I and G o to inhibit adenylyl cyclase activity [1, 2] . D 1 -like receptors are typically expressed post-synaptically/postjunctionally, whereas D 2 -like receptors are also expressed pre-synaptically/pre-junctionally. Distinct cells within the same organ may co-express different receptor subtypes, rendering cell-specific assignment of receptor subtypes difficult [2, [7] [8] [9] [10] [11] [12] [13] [14] . Dopamine receptor agonists and antagonists have poor selectivity for individual dopamine receptors and, consequently, hinder investigation of the specific roles of each dopamine receptor subtype. To circumvent this problem, gene-targeted mutant mouse models lacking one or more dopamine receptor subtypes [8] [9] [10] [11] [12] [13] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] have been generated. Studies using these mouse models have shed light on the specific physiological role of each receptor at the cell, organ, and whole animal level.
The long-term regulation of blood pressure is accomplished by both renal and non-renal mechanisms [1, 2, [27] [28] [29] [30] [31] . Abnormalities in renal epithelial ion transport play important roles in the pathogenesis of essential hypertension, especially in salt-sensitive hypertension. In this review, we summarize the role of the dopamine receptor subtypes in the regulation of blood pressure in humans and rodents.
Renal distribution of the dopamine receptors

D 1 receptor
Human D 1 receptor mRNA is expressed in cultured human renal proximal tubule cells [32] . In the human kidney [33] , D 1 receptor immunostaining is found in the apical and basolateral membrane of the proximal and distal convoluted tubules, medullary thick ascending limb of Henle, macula densa, and cortical collecting duct, but not in the glomerulus and juxtaglomerular cell. D 1 receptor protein is also present in the large intrarenal arteries in humans [33] , but not in renal veins. Immunoblotting studies have revealed the presence of several forms of D 1 receptors, varying in size from 50 to 210 kDa, in rat and human renal proximal tubules [34] , which is in agreement with data obtained in brain tissue [35] .
Rat Radioligand binding studies of the rat have shown the presence of D 1 -like receptors in the renal cortex, but not in glomeruli or medulla [36] [37] [38] [39] [40] [41] . However, ligands to both D 1 -like receptors have similar affinities and, therefore, cannot pharmacologically distinguish the D 1 from the D 5 receptor. D 1 receptor mRNA is expressed in the rat proximal and distal tubule, arteriole, juxtaglomerular apparatus, but not in the glomerulus or medulla [42] [43] [44] . It is also expressed in cultured renal proximal tubule cells from the rat [45] , mouse (unpublished studies), opossum [46] , human [32] , and pig [47] . D 1 receptor immunostaining is present in the rat apical and basolateral membrane of the proximal and distal convoluted tubules, medullary thick ascending limb of Henle, macula densa, and cortical collecting duct [7, 48] . Most of the D 1 receptors in the rat proximal tubules are located in the S3 segment (unpublished observations, 2007) . The protein expression of D 1 receptors in the inner medullary collecting duct has not been documented, but dopamine does not stimulate cyclic adenosine monophosphate (cAMP) production in this nephron segment [49] . The expression of D 1 receptors in the juxtaglomerular cell [7, 44, 48] has been reported in the rat, but not in the human or mouse kidney. Consistent with the results from mRNA studies and adenylyl cyclase activation in response to D 1 -like receptor agonist [2] , D 1 receptor proteins are not expressed in the rat glomerulus.
Mouse The distribution of D 1 receptor protein in the renal tubular segments in the mouse ( [2] , unpublished studies) is similar to that in the human and rat kidney.
D 2 receptor
There are two D 2 receptor isoforms, D 2short and D 2long , which have been suggested to function pre-and postsynaptically, respectively [50] . The D 2short receptor is expressed more in pre-than in post-synaptic junctions [51, 52] .
Rat D 2long mRNA is expressed in renal tubules and glomeruli [53] . Immunoblotting [54] revealed that D 2 receptor protein is expressed in rat kidney cortex at a major band of 63 kDa and a minor protein band of 95 kDa (probably a D 2 receptor dimer). By indirect immunofluorescence microscopy, D 2 receptor immunostaining is found in the rat renal cortical proximal tubule, collecting duct, and the mesangial cell of the glomerulus [54] . The D 2 receptor is expressed in the intercalated-but not in the principal cellof the medullary collecting duct. D 2 receptor protein is also expressed in an opossum proximal tubule cell line, which also exhibits distal tubular cell characteristics [55] . There are no reports of renal tubular D 2 receptor expression in the human and mouse.
D 3 receptor
Human There are no published studies on the location of the D 3 receptor in non-embryonic human kidney.
Rat Radioligand binding of 7-OH-DPAT, a selective D 2 and D 3 receptor ligand, has been reported in rat cortical tubules and mesangial cells [56] . D 3 receptor mRNA is expressed in the glomeruli, renal cortical and medullary tubular, and intrarenal vascular tissues [53] . In renal proximal tubules, D 3 receptor protein is mainly located in the apical and subapical areas, but not in the basolateral membrane [57] . However, results on the expression of the rat D 3 receptor along the nephron and blood vessels have not been consistent. Nurnberger et al. [57] found D 3 receptor protein to be limited to the proximal tubule, whereas O'Connell et al. [58] found the receptor protein in the glomerulus, renal blood vessel, renal proximal tubule, the apical membrane of the distal convoluted tubule, in the intercalated cell of the cortical collecting duct, and in the macula densa of the rat kidney, but not in juxtaglomerular apparatus. However, D 3 receptor mRNA and functional D 3 receptors have been described in primary cultures of rat juxtaglomerular cells [59] . The discrepancy between the findings in the kidney in situ and juxtaglomerular cells in vitro suggests that the expression of D 3 receptors is conditional (e.g. culturedependent). Two species of D 3 receptor (45 and 90 kDa) are expressed in rat renal proximal tubule brush border membranes [60] and cells [61] , as detected by immunoblotting studies.
Mouse D 3 receptor immunostaining is observed at the apical membrane of the S1 segment of the proximal convoluted tubule. The staining is also found in the macula densa, cytoplasm of the thick ascending limb of Henle, distal convoluted tubule, and the glomerulus, but not in the medullary collecting duct [62] .
D 4 receptor
Human D 4 receptor mRNA is expressed in the human kidney [63] .
Rat D 4 receptor mRNA is not expressed in the glomerulus or the loop of Henle [63] , but the D 4 receptor protein is found in cultured rat juxtaglomerular cells [59] . Immunoblotting analysis of the renal cortex has revealed a minor protein band of 49 kDa and a major protein band of 38 kDa [54] . D 4 receptor immunostaining is present in the S 1 segment of the proximal tubule, the distal convoluted tubule [64] , and especially in the cortical and medullary collecting ducts, where it is more prominent at the basolateral area than at the luminal areas. D 4 receptor staining is weak in the glomerulus [54] .
Mouse There are no reports on the expression of the D 4 receptor in the mouse kidney. Our unpublished studies indicate that the D 4 receptor is expressed throughout the nephron, except at the thick ascending limb of Henle (Fig. 1 ).
D 5 receptor
Human D 5 receptor protein is expressed in cultured proximal tubule cells from the human kidney [65] .
Rat The D 5 receptor protein is expressed in the proximal and distal convoluted tubules, and arteriole, but not in the juxtaglomerular cell, glomerulus, or macula densa [7, [66] [67] [68] . The D 5 receptor may be expressed preferentially over the D 1 receptor in the thick ascending limb of Henle and the cortical collecting duct, while the D 1 receptor is preferentially expressed in the proximal tubule [69, 70] . Immortalized rat renal proximal tubule cells express D 5 receptors of molecular sizes similar to those of the D 1 receptor [71, 72] . The D 5 receptor is also expressed in the opossum kidney, but not in the opossum kidney cell line [46] .
Mouse The D 5 receptor immunostaining is located in the apical and brush border membrane of mouse renal cortical tubule [72] .
Role of the dopamine receptors in renal physiology
The D 1 -like receptors Dopamine produced by the renal proximal tubule plays an important role in the regulation of sodium excretion, especially when there is a surfeit of sodium in the system [1, 2] . The D 1 -like dopamine receptors, D 1 R and D 5 R, account for 50-70% of renal sodium excretion [1, 2] during moderate sodium intake. The inhibition of sodium transport exerted by endogenous renal dopamine is due mainly to renal tubular effects [2, 38, 73] , in contrast to exogenously administered dopamine and D 1 -like receptor agonists which regulate sodium excretion by both hemodynamic and tubular mechanisms [1, 2, 14, 38, 74- 
D 4 receptor and renal function
The D 4 receptor exerts an antagonistic effect on vasopressin-and aldosterone-dependent water and sodium reabsorption in the cortical collecting duct [145, 146] . In the rabbit cortical collecting duct, the D 4 receptor-mediated decrease in sodium transport is exerted mainly at the basolateral membrane despite of greater expression of D 4 receptors at the luminal membrane [146] .
The distribution of dopamine receptors and apical sodium transporters in rat renal tubules is summarized in Fig. 1 .
Aberrant dopamine receptor function and hypertension
D 1 -like receptors and hypertension
The diuretic and natriuretic responses to administration of D 1 -like receptor agonists are impaired in rodents with polygenic hypertension (Dahl salt-sensitive rats and SHRs) [1, 2, 38, 75, 147] . The natriuretic effect of parathyroid hormone and cholecystokinin is not impaired in the SHRs, indicating that the impaired D 1 -like receptor effect is receptor-specific [60] . More importantly, the natriuretic effect of dopamine synthesized in the kidney is also impaired in rodent polygenic hypertension [38, 60, 147] . In human essential hypertensive subjects, the actions of D 1 -like receptors on renal hemodynamics and distal renal tubule function (see below) are preserved [148, 149] , and for this reason, the overall natriuretic effect of administered D 1 receptor agonists may be similar or even greater than that in normotensive subjects, even when the ability of D 1 -like receptor agonists to inhibit proximal tubular reabsorption is impaired [148] . The impaired ability of D 1 -like receptors to stimulate cAMP production in renal proximal tubules is receptor specific, since the ability of parathyroid hormone to stimulate cAMP production or stimulate G proteins is intact [153, 155, 156] and, at least in young SHRs, β-adrenergic function is also intact [157] . Increased serine phosphorylation and decreased expression of D 1 receptors at the plasma membrane [71, 158] , are responsible for the impaired ability of D 1 -like receptors to stimulate cAMP production in renal proximal tubules in genetic hypertension. However, the impairment of D 1 -like receptor function is organ specific because D 1 -like receptor function in the brain striatum is intact [37] . The D 1 -like receptor defect is genetic because it co-segregates with high blood pressure and precedes the onset of hypertension [16, 37, 159, 160] .
Deficiency of the expression of D 1 -like receptors could be involved in human essential hypertension. The human D 1 gene locus on chromosome 5 at q35.1 is linked to human essential hypertension [161] . Although there are as yet no reports of the association of polymorphisms of the coding region of the D 1 receptor and essential hypertension, a polymorphism, A-48G, in the 5′-untranslated region is associated with essential hypertension in Japanese [162]-but not in Caucasians [163] . However, the D 1 receptor A-48G polymorphism has been reported to be associated with albuminuria [164] .
The D 5 receptor gene locus (chromosome 4p15.1-16.1) is also linked to essential hypertension [165] ; the human D 5 receptor gene has polymorphisms that code for receptors abnormally coupled to adenylyl cyclase [166] . The role of the D 5 receptor in hypertension has been difficult to determine, mostly due to the fact that the D 1 [16, 22] . The homozygous D 1 -/-mice have no binding sites for D 1 -like receptor antagonists, and in response to D 1 -like receptor agonist stimulation, they do not increase cAMP accumulation although their response to parathyroid hormone is intact. Systolic, diastolic, and mean arterial pressures are higher in both homozygous and heterozygous mice than in wild-type mice. These data indicate that defective D 1 receptor/signal transduction results in increased blood pressure in mice [16] . However, there is no report available on the renal function or the activity of the renin-angiotensin II-aldosterone system in D 1 -/-mice. It is also unknown whether the hypertension of the null mice is salt-dependent. (Table 1 , unpublished data). D 5 -/-mice have a greater epinephrine/ norepinephrine ratio and a greater hypotensive response to the acute administration of an α-adrenergic blocker [23] than their D 5 +/+ littermates, indicating that increased sympathetic activity plays a role in the elevated blood pressure. However, the percentage decrease in systolic blood pressure, after adrenalectomy, is similar in D 5 -/-and D 5 +/+ mice, indicating that central nervous system mechanisms are involved in the hypertension of D 5 -/-mice [23, 168] . In addition, these central nervous system mecha-nisms, AT 1 receptors, and the increased production of reactive oxygen species (ROS) are also involved in the hypertension of D 5 -/-mice [14, 66, 72, 169] . However, renal renin protein expression and serum aldosterone level are not altered in D 5 -/-mice (unpublished data). D 5 -/-mice also exhibit proteinuria [170] . [171, 172] . Moreover, transfer of the segment of chromosome 8 containing the D 2 receptor gene from the normotensive BrownNorway rat onto an SHR background decreases blood pressure [173] .
The D 3 Ser9Gly receptor variant heterologously expressed in CHO cells impairs D 3 receptor-mediated inhibition of cAMP production, although these cell do possess the ability to decrease prostaglandin E2 (PGE2) production [174] . However, there is no association between the D 3 Ser9Gly, or other D 3 receptor gene variants with hypertension [175] , despite the chromosome locus of the D 3 receptor gene (3q13.3) having been linked to human essential hypertension [176, 177] . Several studies have demonstrated that D 3 receptor deficiency may be important in the development of salt-sensitive hypertension. Saltresistant Dahl rats on a high sodium diet and chronically treated with a highly selective D 3 receptor antagonist have increased blood pressure [178] . The natriuretic effect of a D 3 agonist is not evident in hypertensive salt-sensitive Dahl rats [178] . The same research group did not find differences in the natriuretic effect of a D 3 agonist between WKY rats and SHRs [179] . In this study, however, the D 3 agonist is given systemically, and activation of D 3 receptors outside the kidney may have had compensating role, thereby obscuring a differential effect on sodium excretion between WKY and SHRs. When the selective D 3 receptor agonist, PD128907, is infused directly into the renal artery in WKY rats and SHRs 4 receptor protein, a region that appears to interact with G proteins and influence intracellular levels of cAMP [182] . The number of repeats at the D 4 site varies from two to ten, but the four and seven repeat lengths are the most common in Caucasians in whom the long variant of the D 4 gene is associated with increased systolic and diastolic blood pressures [183] .
The effects of D 4 agonists and antagonists on cardiovascular and renal function in genetically hypertensive rats have not been reported. The D 4 receptor protein is increased in the renal cortex-but not in the inner medulla-of SHRs relative to WKY rats [54] .
D 2 receptor mutant mice
The D 2 receptor gene deficient (D 2 -/-) mice were generated by homologous recombination in embryonic stem cells with deletion of exon 7 and the 5′ half of exon 8. These regions encode the majority of the putative third intracellular loop, the last two transmembrane domains, and the carboxy terminus [24] . D 2 -/-mice have decreased initiation of movement but otherwise normal basic motor skills without tremor, ataxia, or abnormal stance or posture. D 2 -/-and D 2 -/+ mice have higher systolic and diastolic blood pressures than D 2 wild-type (D 2 +/+) mice. The ability of D 2 -/-mice to excrete an acute saline load is similar to that of D 2 +/+ mice regardless of the elevated blood pressure, indicating that D 2 -/-mice have a blunted pressure-natriuresis response. α-Adrenergic blockade decreases blood pressure to a greater extent in D 2 -/-mice than in D 2 +/+ mice. Epinephrine excretion is greater in D 2 -/-mice than in D 2 +/+ mice, and acute adrenalectomy decreases blood pressure to a similar level in D 2 -/-and D 2 +/+ mice. Endothelin B (ETB) receptor expression is greater in D 2 -/-mice than in D 2 +/+ mice, and an ETB receptor blocker decreases blood pressure in D 2 -/-mice but not D 2 +/+ mice. D 2 -/-mice may be hypertensive because of enhanced vascular reactivity caused by increased sympathetic and ETB receptor activities [24] as well as by increased ROS production [184] . The D 2 -/-mice also have increased production of aldosterone, and treatment with a mineralocorticoid receptor blocker normalizes blood pressure in these mice [184] . In contrast, D 2 +/-mice have normal urinary aldosterone levels [185] .
In another strain of D 2 -/-mice, blood pressure is only increased when the animals are fed a high-salt diet, and this condition is associated with a decrease in renal aromatic Lamino acid decarboxylase (AADC) activity and renal dopamine production [26] ; AADC converts L-DOPA (levodopa), which is taken up by renal brush border membranes, to dopamine. Sympathetic activity is not increased in these D 2 -/-mice. Basal urine flow and sodium excretion are lower in D 2 -/-mice than in D 2 +/+ mice. However, administration of dopamine increases urine volume and sodium excretion in D 2 -/-mice to levels similar to those found in D 2 +/+ mice [118] . The differences between the two strains of D 2 -/-mice could be related to differences in their genetic backgrounds. [17] or in congenic C57BL/6 background [62] . In contrast, Staudacher et al. reported that D 3 -/-mice in a congenic C57BL/6 background and on a low, normal, or high salt intake have normal blood pressure [186] . This report has to be interpreted with caution because C57BL/6 mice from Jackson Laboratories develop hypertension when fed a high NaCl diet [187] , while those from Taconic [169] do not. The two strains of D 3 -/-mice, however, have a decreased ability to excrete an acute or a chronic sodium chloride load [17, 186] , which may lead to an expansion of the extracellular fluid volume. Thus, disruption of the D 3 receptor results in sodium retention, but the hypertension is also related to increased renal renin production. Renal renin activity and AT 1 receptor expression are greater in D 3 -/-than in wild-type mice, and blockade of AT 1 receptors decreases systolic blood pressure more effectively in D 3 -/-mice than in wild-type ones [17] . Urinary aldosterone levels are not altered in D 3 -/-mice (unpublished data). Some phenotypes related to renal function in dopamine receptor deficient mice are summarized in Table 1 .
Development of renal dopamine
Development of renal dopamine synthesis Dopamine-mediated natriuresis and renal vascular effects are less in younger animals than in older ones. An inverse correlation between urinary dopamine and age has been reported in adults [188, 189] . The excretion of dopamine is higher in the pediatric population than in elderly subjects [190] . However, urinary dopamine increases postnatally in very low birth weight infants [191, 192] . In rats, intrarenal levels of dopamine have a tendency to increase between 3 and 20 days after birth, but significantly decrease between 20 to 80 days after birth [193] . Urinary excretions of dopamine and its deaminated metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) [194] , as well as dopamine formation in kidney slices, are markedly decreased in old rats, which have been attributed to decreased uptake of L-DOPA by tubular brush-border membranes [194, 195] . The uptake of L-DOPA is the rate-limiting step in the renal synthesis of dopamine [194] . The activity of aromatic AADC, the enzyme involved in the renal synthesis of dopamine, however, increases with age [195] . The activity of AADC is higher in the adult dog kidney than in 10-day or 2-month-old dogs [196] . In the rat, AADC immunoreactivity can be observed in renal tubule cells as early as gestational day 18 and is present in proximal tubules in the outer and inner cortex 5 days after birth. Aromatic L-amino acid decarboxylase mRNA is present in the entire cortex by the sixth post-natal day [193] .
Development of renal dopamine receptors
In the rat, renal dopamine D 1 -like and D 2 -like receptor densities approach adult values by 3 weeks of age [197, 198] . Rat renal D 1 receptors are present by the 15th day of gestational age and increase with maturation [199] . Renal D 1 receptors are also expressed in fetal sheep [200] . However, in the sheep, the renal cortical affinity or maximum receptor of D 1 -like receptors, as determined by radioligand binding, does not change with maturation [201] .
In rats, renal D 2 -like receptor binding does not change within the first 2 weeks of life but increases after 3 weeks [202] . In contrast, renal D 2 -like receptor binding decreases with age in sheep [201] .
Renal effects of dopaminergic agonists
The decreased natriuretic action of dopamine and D 1 -like receptor agonists in the young and the aged has been attributed to a decreased renal generation of cAMP and inhibition of NHE3 and Na + /K + ATPase activity in response to D 1 -like receptor stimulation [198, [201] [202] [203] [204] [205] [206] [207] [208] . Even though renal D 1 -like receptor densities are not different between 3-and 10-week-old rats, there is an impaired ability of the D 1 -like agonist fenoldopam to stimulate adenylyly cyclase activity in the young [198, 203] . The decreased inhibitory effect of D 1 -like receptors on NHE activity in young rats is caused, in part, by the increased expression and activity of the G protein subunit G β/γ [208] .
In neonatal dogs, pigs, and sheep, the intravenous or intrarenal arterial administration of dopamine alone may not always increase renal blood flow or decrease renal vascular resistance [209] [210] [211] [212] [213] . The systemic or intrarenal arterial infusion of dopamine alone, even in low doses, may result in a renal vasoconstriction that is more pronounced in the fetal and neonatal animals [209, 211, 213] . This is due to the occupation of renal α adrenergic receptors that increase in number in the perinatal dog and sheep. A low dose of dopamine injected into the renal artery increases renal blood flow and decreases renal vascular resistance in adult dogs [214] , but not in young puppies [215] . Even in the presence of α-and β-adrenergic blockade, dopamine does not increase renal blood flow in 1-to 2-week-old puppies, but it does increase renal blood flow and glomerular filtration rate in older puppies [215] . Similar results are observed following intravenous dopamine administration in young piglets [211] . In spite of the absence of any change in renal blood flow following intrarenal arterial infusion of dopamine, sodium excretion increases, but this effect is less evident in the younger puppy than in the older one [215] . Dopamine also increases sodium excretion in the fetal sheep without increasing renal blood flow [213, 216] . Thus, in the very young, the natriuretic effect of dopamine is probably due mainly to tubular factors.
The effects of the D 2 -like receptor agonist are not well studied. However, in the developing animal, selective D 2 -like receptor agonists increase glomerular filtration rate to a similar extent as that found in younger and older rats [217] . In premature infants, in contrast to the findings in adults, a predominantly D 2 -like receptor antagonist increases urine flow, sodium excretion, and osmolar clearance, suggesting that D 2 -like receptor effects may predominate in the human infant [218] .
Ability to excrete a salt load in human neonates
Pre-term infants have a decreased ability to retain sodium, but both full-term and pre-term infants have a decreased ability to excrete a salt load [219] . In the pediatric age group, a decrease in sodium intake results in an increase in urinary dopamine, while in adults, a high salt intake results in an increase in urinary dopamine [212, 218] . Low doses of dopamine, however, can induce a natriuresis in preterm infants, but it is not known if the magnitude of the response is different from that reported in the adult [220] . Deficits in renal dopamine function may be responsible for the diminished ability of the aged kidney to excrete a salt load [221] . Whether this is also true in the neonate has not been determined.
Overall summary
In summary, dopamine receptors are important players in the regulation of renal function and blood pressure. Each dopamine receptor subtype exerts a unique regulatory function and interacts with other GPCRs, especially those related to angiotensin II. All dopamine receptor subtypes are present in the kidney, showing a distinct distribution along the nephron. Renal sodium transport is regulated by all subtypes, either directly or indirectly by interaction with other GPCRs, to maintain sodium balance. Deletion of any of the dopamine receptor subtypes results in elevated blood pressure and impaired pressure natriuresis in the mutant mice. Abnormalities of dopamine receptors in their genes/ proteins or in their regulation of renal function play an important role in the pathogenesis of hypertension. 
